- Accelerated telomere loss in patients with severe congenital neutropenia (SCN)
- Administration of r-met Hu G-CSF during pregnancy in patients with severe chronic neutropenia (SCN)
- Administration of r-metHuG-CSF during pregnancy in patients with severe chronic neutropenia (SCN)
- Algorithm for the management of Kostmann’s neutropenia based on data from the Severe Chronic Neutropenia International Registry
- Altered function and surface marker expression of neutrophils induced by rhG-CSF treatment in severe congenital neutropenia
- Anticipation in autosomal dominant cyclic hematopoiesis
- Beneficial effects of stem cell factor (SCF) in children with severe congenital neutropenias refractory to G-CSF
- Bone marrow transplantation (BMT) in patients with severe congenital neutropenia refractory to G-CSF
- Clinical course of autoimmune neutropenia in infancy
- Correction of neutropenia and associated clinical symptoms with rhG-CSF in children with severe congenital neutropenia
- Correction of neutropenia in children with glykogenosis 1b by treatment with rhG-CSF
- Correction of severe congenital neutropenia and associated clinical symptoms in children with recombinant human granulocyte-colony stimulating factor (rhG-CSF)
- Correction of severe congenital neutropenia in children with recombinant human granulocyte-colony stimulating factor (rhG-CSF)
- Decreased neutrophil elastase activity in patients with severe congenital neutropenia is not correlated to mutations in ELA2
- Development of AML/MDS in a subset of patients (PTS) with severe chronic neutropenia (SCN)
- Development of glomerulonephritis in patients (pts) with severe chronic neutropenia (SCN)
- Effects of recombinant human interleukin-3 (rhIL-3) in chemotherapy induced myelosuppression in primates
- G-CSF receptor mutations in patients with severe chronic neutropenia: a step in leukemogenesis?
- G-CSF receptor mutations in patients with severe congenital neutropenia: Frequency and implications in leukemic development
- Granulocyte-colony stimulating factor (G-CSF) fort he treatment of adult patients with chronic idiopathic neutropenia and cyclic neutropenia
- Growth among patients with severe chronic neutropenia treated with Filgrastim (G-CSF)
- Immunosuppressive therapy (IST) and bone marrow transplantation (BMT) for Aplastic Anamia (AA) in children: Results of the study SAA 94
- Impaired mobilization of cytosolic free calcium in neutrophils from patients with severe congenital neutropenia
- In vivo effects of interleukin-6 on hematopoiesis in primates
- In vivo production of granulocyte colony-stimulating factor (G-CSF) in patients with severe congenital neutropenia
- In vivo regulation of thrombopoiesis by leukemia inhibitory factor (LIF)
- Interleukin-6 regulates thrombopoiesis in primates.
- Korrektur der schweren kongenitalen Neutropenie und assoziierter klinischer Symptome bei Kindern mit rekombinantem humanen Granulozyten-Kolonien stimulierendem Faktor
- Langzeitbehandlung mit G-CSF bei Kindern mit schweren kongenitalen Neutropenien
- Leukemia inhibitory factor (LIF) induces thrombocytosis in primates
- Long term follow up on patients with glycogen storage disease 1b and severe chronic neutropenia treated with G-CSF
- Long term treatment of chronic idiopathic neutropenia in women with G-CSF
- Long-term effects of rhG-CSF treatment in patients with severe congenital neutropenia
- Long-term treatment of chronic idiopathic neutropenia with G-CSF
- Long-term treatment with recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with severe congenital neutropenia
- MDS/AML in patients with severe chronic neutropenia (SCN) receiving G-CSF
- Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia (CN) treated with recombinant human granulocyte colony stimulating factor (rh-G-CSF)
- Morphologic assessment of marrow aspirates in Severe Congenital Neutropenia (CN) fails to predict evolution to myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML)
- Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause congenital neutropenia
- Mutations of the G-CSF receptor gene in AML secondary to severe congenital neutropenia
- Neutropenia in Barth Syndrome: Clinical Course and Treatment of neutropenia
- Outcomes for hematopoietic stem cell transplantation (HSCT) in severe congenital neutropenia (CN)
- Report on patients with Shwachman-Diamond syndrome with severe chronic neutropenia
- Report on patients with glycogen storage disease 1b with severe chronic neutropenia (SCN) treated with Filgrastim
- Severe chronic neutropenia: Report on treatment and outcome from a new international registry
- The diversity of neutrophil elastase mutations in congenital neutropenia
- The molecular genetic basis of cyclic hematopoiesis
- Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia
- Update on the G-CSF receptor gene mutations in patients with severe congenital neutropenia (CN)